Clinical Trial Update: Melatonin as Adjuvant Treatment for ADHD in Adults [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating melatonin as an adjuvant treatment for attention deficit hyperactivity disorder in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: UNKNOWN